Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.49% | 34.65 | 0.9% | $1168.91m | |
| JNJ | Johnson & Johnson | 0.62% | 131.35 | 0.7% | $908.58m | |
| MRK | Merck & Co., Inc. | 1.92% | 85.06 | 0.6% | $797.24m | |
| BMY | Bristol-Myers Squibb Company | 2.67% | 46.97 | 1.4% | $680.66m | |
| ABBV | AbbVie, Inc. | 2.30% | 64.43 | 2.3% | $610.53m | |
| LLY | Eli Lilly and Company | 0.24% | 110.49 | 1.0% | $456.04m | |
| NVS | Novartis AG Sponsored ADR | 0.99% | 89.46 | 0.2% | $209.31m | |
| AZN | AstraZeneca PLC Sponsored ADR | 0.39% | 44.35 | 1.2% | $166.53m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | 0.60% | 40.20 | 0.3% | $95.35m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | 2.70% | 51.65 | 0.1% | $81.50m | |
| SNY | Sanofi Sponsored ADR | 0.89% | 42.02 | 0.2% | $56.34m | |
| LCI | Lannett Company, Inc. | 4.31% | 6.77 | 36.6% | $10.92m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | -5.37% | 1.94 | 1.6% | $3.62m | |
| EPIX | ESSA Pharma Inc | 3.28% | 1.51 | 0.1% | $0.03m |
Company Profile
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant, or MDR, bacterial infections. Its pipeline product candidates include SPR994, SPR741, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.